Suppr超能文献

输血效应。

The transfusion effect.

作者信息

Cecka M, Toyotome A

出版信息

Clin Transpl. 1989:335-41.

PMID:2487601
Abstract
  1. Many transplant centers have apparently abandoned their deliberate transfusion protocols believing that the beneficial effect of transfusions no longer outweighs the risks. 2. Pretransplant blood transfusions have consistently improved graft survival among recipients of first cadaver donor transplants. One-year graft survival rates were 5-8% higher for transfused patients transplanted each year between 1982 and 1987. Transplants performed in 1988 and 1989 showed a 3% improvement with transfusions. 3. Whereas large numbers of transfusions resulted in higher 1-year graft survival rates in the precyclosporine era, 2 or 3 transfusions provided the maximum effect in more recent transplants. 4. A disturbing decrease in the long-term survival of transplants to nontransfused patients and patients given 1-4 transfusions has been noted. Nontransfused recipients transplanted since 1985 had a higher loss rate after the first year than those transplanted prior to 1982. If this trend can be verified as more follow-up becomes available, it suggests that the transfusion effect has become a factor in long-term survival rather than one that affects only the immediate posttransplant period. 5. Transfusions decreased the risk and apparent severity of early rejection episodes. Twenty-six percent of transfused patients had early rejection and 1-year graft survival was 67%. Among nontransfused patients, rejections occurred in 42% and survival was 56%. Patients with no early graft dysfunction had 89% 1-year graft survival when transfused and 83% when not transfused. 6. Transfusions improved 1-year graft survival by 7% for Asian recipients, 6% for Blacks, and 4% for Whites. The improvement within each racial group was significant. 7. Kidneys that were mismatched for HLA-DR antigens and kidneys from donors younger than age 16 had significantly poorer survival when transplanted to nontransfused patients. Transfusions mitigated the effects of mismatching and donor age on 1-year graft survival.(ABSTRACT TRUNCATED AT 250 WORDS)
摘要
  1. 许多移植中心显然已经摒弃了他们精心制定的输血方案,认为输血的益处不再大于风险。2. 移植前输血一直能提高首次尸体供体移植受者的移植物存活率。1982年至1987年期间每年接受输血的移植患者,其一年移植物存活率高出5 - 8%。1988年和1989年进行的移植手术显示,输血使存活率提高了3%。3. 在环孢素时代之前,大量输血可提高一年移植物存活率,但在最近的移植手术中,2至3次输血效果最佳。4. 已注意到,移植到未输血患者和接受1 - 4次输血患者体内的移植物长期存活率出现了令人不安的下降。自1985年以来接受移植的未输血受者,第一年之后的损失率高于1982年之前接受移植的患者。如果随着更多随访结果的出现,这一趋势能够得到证实,那就表明输血效应已成为影响长期存活的一个因素,而不仅仅影响移植后的即刻阶段。5. 输血降低了早期排斥反应的风险和明显严重程度。26%接受输血的患者发生早期排斥反应,一年移植物存活率为67%。在未输血患者中,排斥反应发生率为42%,存活率为56%。没有早期移植物功能障碍的患者,输血后一年移植物存活率为89%,未输血时为83%。6. 输血使亚洲受者的一年移植物存活率提高了7%,黑人提高了6%,白人提高了4%。每个种族群体内部的提高都很显著。7. 移植到未输血患者体内时,HLA - DR抗原不匹配的肾脏以及来自16岁以下供者的肾脏存活率明显较低。输血减轻了不匹配和供者年龄对一年移植物存活率的影响。(摘要截选至250词)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验